SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 4 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,346,000 | -83.7% | 23,700 | -78.5% | 0.00% | -100.0% |
Q1 2021 | $8,241,000 | +115.5% | 110,100 | +149.1% | 0.00% | 0.0% |
Q4 2020 | $3,824,000 | +153.2% | 44,200 | +74.7% | 0.00% | – |
Q3 2020 | $1,510,000 | +3495.2% | 25,300 | +2430.0% | 0.00% | – |
Q2 2020 | $42,000 | -99.5% | 1,000 | -99.1% | 0.00% | -100.0% |
Q4 2019 | $8,316,000 | +29600.0% | 115,200 | +57500.0% | 0.00% | – |
Q3 2019 | $28,000 | -22.2% | 200 | 0.0% | 0.00% | – |
Q2 2019 | $36,000 | -99.9% | 200 | -99.9% | 0.00% | -100.0% |
Q1 2019 | $53,282,000 | +4115.3% | 335,000 | +1566.7% | 0.01% | – |
Q3 2017 | $1,264,000 | – | 20,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 72,900 | $11,595,000 | 0.13% |
SIMPLEX TRADING, LLC | 266 | $4,230,000 | 0.01% |
JPMORGAN CHASE & CO | 335,000 | $53,282,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |